FDA Removes Boxed Warning from LABA/ICS Inhalers Following Postmarket Studies

Drug Industry Daily
A A
The FDA removed its Boxed Warning regarding asthma-related death from the labels of medicines containing long-acting beta agonists in combination with inhaled corticosteroids, following postmarket studies of possible side effects.

To View This Article:

Login

Subscribe To Drug Industry Daily